Clinical Trial Update: Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

This is a Phase 3 trial comparing panitumumab plus supportive care to best supportive care alone in patients with metastatic colorectal cancer. Results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-04-08